Cargando…
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
Autores principales: | Brugnatelli, Viola, Turco, Fabio, Freo, Ulderico, Zanette, Gastone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186328/ https://www.ncbi.nlm.nih.gov/pubmed/32372912 http://dx.doi.org/10.3389/fnins.2020.00371 |
Ejemplares similares
-
Analgesic and Antidepressant Effects of the Clinical Glutamate Modulators Acetyl-L-Carnitine and Ketamine
por: Freo, Ulderico, et al.
Publicado: (2021) -
Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications
por: Brugnatelli, Viola, et al.
Publicado: (2021) -
Gut Microbiota Manipulation in Irritable Bowel Syndrome
por: Mazzawi, Tarek
Publicado: (2022) -
Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health
por: Turco, Fabio, et al.
Publicado: (2023) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)